Humana Price Target Slashed 28% to $176, Acquires MaxHealth for $1B
Barclays reduced Humana's price target to $176 from $245, expressing caution over Medicare Advantage margin expansion. Humana also agreed to acquire Florida clinic operator MaxHealth in a deal around $1 billion, adding 80+ clinics and 120,000 patients to its CenterWell network.
1. Barclays Cuts Price Target to $176
On February 25, Barclays lowered Humana's price recommendation from $245 to $176 while maintaining an Equal Weight rating. The firm cited incremental caution regarding the company’s expectation that Medicare Advantage margins will double, weighing on near-term profitability outlook.
2. Acquisition of MaxHealth Expands CenterWell Footprint
Humana agreed to acquire Florida-based clinic operator MaxHealth in a transaction valued at approximately $1 billion. The deal adds over 80 clinics and more than 120,000 patients in West and South Florida to Humana’s CenterWell Senior Primary Care division, strengthening its primary care network.